Explore All Access
Check if your research matches the topics covered in Liver Cancer?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Liver Cancer : Impact Factor & More
eISSN: 1664-5553pISSN: 2235-1795
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Liver Cancer Key Metrics
CiteScore 
12.6
H-Index
48
Impact Factor
10 - 15
SJR
Q1Oncology
SNIP
2.38
Topics Covered on Liver Cancer
Liver cancer
Overall survival
Hepatocellular carcinoma
Clinical trial
Lenvatinib
Tumor microenvironment
Confidence interval
Pembrolizumab
Magnetic resonance imaging
Bevacizumab
Hazard ratio
Hepatitis B
Radiofrequency ablation
Atezolizumab
Systemic therapy
Hepatic arterial infusion chemotherapy
Tumor grade
Treatment options
Sorafenib
Disease progression
Liver Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | KARGER |
| Language | English |
| Frequency | Bi-monthly |
| Article Processing Charges | EUR 3260 | USD 3770 | CHF 3390 |
| Publication Time | 23 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Eastern & Western Association Liver Tumors |
| Frequency | Bi-monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Liver Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Liver Cancer
Acknowledgement to Reviewers
- 18 Nov 2024
- Liver Cancer
First-Line Lenvatinib Plus Pembrolizumab for Hepatocellular Carcinoma: Post Hoc Analysis of Japanese Patients From the Phase 3 LEAP-002 Trial
- 14 Nov 2024
- Liver Cancer
Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features Can Predict Immune-Excluded Phenotype of Hepatocellular Carcinoma
- 13 Nov 2024
- Liver Cancer
Demographics and Immunotherapy Efficacy for Advanced Hepatocellular carcinoma: A Systematic Review and Meta-Analysis of Phase III Clinical Trials
- 13 Nov 2024
- Liver Cancer
Comprehensive analysis of radiologic cancer-free (rCF) status through various treatment approaches in advanced-stage hepatocellular carcinoma
- 13 Nov 2024
- Liver Cancer
Challenges in Adjuvant Immunotherapy after Resection or Ablation for High-Risk Hepatocellular Carcinoma at High-Risk of Recurrence
- 24 Oct 2024
- Liver Cancer
Acknowledgement to Reviewers
- 18 Nov 2024
- Liver Cancer
First-Line Lenvatinib Plus Pembrolizumab for Hepatocellular Carcinoma: Post Hoc Analysis of Japanese Patients From the Phase 3 LEAP-002 Trial
- 14 Nov 2024
- Liver Cancer
Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features Can Predict Immune-Excluded Phenotype of Hepatocellular Carcinoma
- 13 Nov 2024
- Liver Cancer
Demographics and Immunotherapy Efficacy for Advanced Hepatocellular carcinoma: A Systematic Review and Meta-Analysis of Phase III Clinical Trials
- 13 Nov 2024
- Liver Cancer
Comprehensive analysis of radiologic cancer-free (rCF) status through various treatment approaches in advanced-stage hepatocellular carcinoma
- 13 Nov 2024
- Liver Cancer
Challenges in Adjuvant Immunotherapy after Resection or Ablation for High-Risk Hepatocellular Carcinoma at High-Risk of Recurrence
- 24 Oct 2024
- Liver Cancer
Compare Similar Journals with Liver Cancer
Select Journals to Compare with Liver Cancer
Total journals - 10
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Annals of Oncology
Publisher: ELSEVIER
Cancers
Publisher: MDPI
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Hepatology Research
Publisher: WILEY
Journal of Hepatology
Publisher: ELSEVIER
Medicine
Publisher: Elsevier
Liver International
Publisher: WILEY
BMC Cancer
Publisher: BMC
ANNALS OF TRANSLATIONAL MEDICINE
Publisher: AME PUBL CO
0 Journals Selected to compare with
Liver Cancer
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Liver Cancer
How long has Liver Cancer been actively publishing? 
Liver Cancer has been in operation since 2012 till date.
What is the publishing frequency of Liver Cancer?
Liver Cancer published with a Bi-monthly frequency.
How many articles did Liver Cancer publish last year?
In 2023, Liver Cancer publsihed 68 articles.
What is the eISSN & pISSN for Liver Cancer?
For Liver Cancer, eISSN is 1664-5553 and pISSN is 2235-1795.
What is Citescore for Liver Cancer?
Citescore for Liver Cancer is 12.6.
What is the H Index for Liver Cancer ?
H Index for Liver Cancer is 48.
What is SNIP score for Liver Cancer?
SNIP score for Liver Cancer is 2.38.
What is the SJR for Liver Cancer?
SJR for Liver Cancer is Q1.
Who is the publisher of Liver Cancer?
KARGER is the publisher of Liver Cancer.
